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4Introduction
Myasthenia gravis is one of the best-studied
immunological disorders. Antibodies on nicotinic
acetylcholine receptors are detectable in about
80% patients with myasthenia gravis. Almost every
patient with myasthenia gravis until age of forty or
forty-five develops hyperplasia of thymus gland.
About 10% of patients with myasthenia gravis de-
velop thymoma, but the nature of the association
is uncertain. Because the thymus is the central or-
gan for immunological self-tolerance, it is reason-741-9409/$ - see front matter c 2004 Published by Elsevier Ltd.
oi:10.1016/j.ooe.2004.11.002
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the breakdown in tolerance that causes an im-
mune-mediated attack on acetylcholine receptors
(AchR) in myasthenia gravis. Approximately 40–
50% thymomas are associated with myasthenia gra-
vis, and rarely they are associated with systemic
lupus erythematosus, progressive systemic sclero-
sis, So¨jgren’s syndrome, chronic mucocutaneous
candidiasis or other disorders.1–4 The secondary
immunodeficiency is the main effect of immuno-
suppressive agents and procedures because this
kind of treatment suppresses immune system gen-
erally and not selectively. This can result in various
bacterial, fungal and viral infections. Candidiasis is
the most common fungal infection in the immuno-
compromised host, and is particularly common in
cancer patients receiving cytotoxic drugs and other
therapies.5,6
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candidiasis together with thymoma and myasthenia
gravis.Case report
A 30 year-old patient was referred to our
Department for evaluation of oral status with de-
tailed medical history. He developed the first signs
and symptoms of myasthenia gravis in 1995 in the
form of disturbances of chewing, swallowing and
talking but they were mild with different fluctua-
tion. The thymoma was accidentaly diagnosed dur-
ing the chest examination by computerizedFigure
Figuretomography. The great transsternal thoracotomy
was performed and thymoma with invasion to
pleura and pericardium was removed by partial
resection of the pleura and pericardium. The
patient underwent chemotherapy treatment and
continued with pyridostigmine bromide and pred-
nosine. Myasthenia gravis signs and symptoms
were compensated but they exaggerated again
after four years and recurrence of the thymoma
was found. The left lateral thoracotomy was per-
formed and tumour tissue was removed. The che-
motherapy was introduced again and the patient
received altogether thirteen cycles. The general
condition of the patient deteriorated rapidly
(Fig 1).1
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sive candidal infection in the mouth together with
bilateral angular cheilitis. The smear from his
mouth was taken and placed on the Saboraud’s
agar for 48 h on the 37 C. This finding showed se-
vere candidal infection. Due to his very poor gen-
eral health, we did not perform biopsy. His
laboratory tests showed increased sedimentation
rate (28; normal range 2–13 according to Wester-
gren), increased white blood cell count (14.7 
109/L; normal range 3.4–9.7  109/L), increased
number of thrombocytes (529  109/L; normal
range 158–424  109/L), decreased level of serum
albumins (46.8 g/L; normal range 57–69 g/L), in-
creased level of a1 (6.0 g/L; normal range 1.7–
3.9 g/L), a2 (14.2 g/L; normal range 5–9.5 g/L)
and c globulins (23 g/L; normal range 12.7–
22.1 g/L). Magnetic resonance of the brain showed
moderate atrophy and severe inflammation of both
maxillary sinuses, ethmoid cells, both mastoid pro-
cesses as well as temporal bone pyramids. At that
time he was under corticosteroid therapy—high sin-
gle dose alternate day (40 mg prednisone) (Fig 2).
The patient was givenmiconazole gel (20 mg/1 g—
three times a day one tea spoon) during fewweeks as
well as antiseptic solution (1 mg/mL hexetidine-
three times a day dilluted into 1 dcL of watter).
Unfortunately, very soon patient deceased (Fig. 3).Discussion
Orofacial manifestations are quite common in
patients with cell mediated immunodeficiencesand candidal infection together with various types
of oral ulcerations could be frequently seen. Yet,
it is still not clear whether these immunologic de-
fects are due to the presence of the thymoma or
whether the thymoma arises as a response to an
underlying immunodeficiency. Also one has to have
on mind the fact that patients receive cytotoxic
drugs which also lead to immunodeficiency. Candi-
diasis is the most common fungal infection in the
immunocompromised host, and is usually charac-
terized with presence of creamy whitish or yellow-
ish plaques on the mucosa of the oral cavity.7 The
disease is not usually life-threatening but it can
lead to diminished food and liquid intake and
therefore it can affect patient’s nutritional sta-
tus. Also spreading of the infection to the esoph-
agus and further can ultimately lead to the
disseminated candidiasis which has been found
to contribute to higher mortality rate in these
patients.8
Porter and Scully2 reported that ulceration of
the tongue, buccal mucosa and palate has been re-
ported in patients with thymoma. Patients may suf-
fer from a wide range of bacterial, viral, fungal and
protozoal infections.
As Rothberg et al.9 have reported, standard pro-
cedure to rule out thymoma should be performed
in all patients who manifest late-onset of severe
and persistent oral candidiasis.
Therefore, we recommend that in every patient
with persistent oral candidiasis or ulceration possi-
bly underlying immune defect should be rouled
out. This article again emphasizes the significant
role of cellular immunity in the oral candidiasis.
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